<p>(<b>A</b>) Colony formation in GFP-labeled LNCaP cells and by crystal violet staining. Colonies indicates clones that exist in a transiently arrested state in the bulk population and resume division when androgen-replete conditions are restored after initial CSS culture. The indicated cells underwent one round of switch back to FBS media (SB1) following senescence in CSS culture. Following 21 days in FBS culture, clonal outgrowths were observed via crystal violet staining (∼0.1%). The insets show light microscopy and FITC images of a representative colony that has begun to proliferate in FBS media. (<b>B</b>) Schematic of the switch back (SB) method for generating androgen-refractory population of cells (designated LNCaP-SB5). (<b>C</b>)...
Effect of incubation with SAMe on the premature-aging phenotype of HGPS cell lines. MTT-based prolif...
Abstract Background Human induced pluripotent stem (iPS) cells have revolutionised research and spar...
Androgen-deprivation is a mainstay of therapy for advanced prostate cancer but tumor regression is u...
<p>(<b>A</b>) Senescence associated beta-galactosidase (SA-beta-gal) staining under indicated condit...
<p>(A) LNCaP 104-R1 cells, PC-3 cells with control plasmid LNCX-2 (PC-3<sup>LNCX-2</sup>), PC-3 cell...
<p>AS LNCaP C-33 cells were seeded at a density of 2×10<sup>4</sup> cells/cm<sup>2</sup> in regular ...
<p>LNCaP cells were transduced with the indicated shRNA constructs and kept continuously in 2 µg/ml ...
<div><p>Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (...
markdownabstract__Abstract_ The LNCaP-FGC (fast growing colony) cell line, a subline derived from...
<p>(A) Immunofluorescent stainings of LNCaP cells after 7 h treatment with R1881 show co-localizatio...
textabstractSeveral effects of androgens on LNCaP-FGC prostate tumor cells showed a biphasic pattern...
<p>LNCaP cells were grown with 0.1-androgen under study. The effects were significant (P<0.01) for a...
<p>(<b>A</b>) Western blot of survival markers in LNCaP cells growing in FBS and CSS day 5, 10 and 1...
<p>L-428 cells were sorted by (A) cell size (small, middle, big) or (B) CD15/CD30 expression (SP, DP...
<p>(A) LNCaP cells were cultivated in media with charcoal-stripped FCS (CS-FCS) or control FCS for 1...
Effect of incubation with SAMe on the premature-aging phenotype of HGPS cell lines. MTT-based prolif...
Abstract Background Human induced pluripotent stem (iPS) cells have revolutionised research and spar...
Androgen-deprivation is a mainstay of therapy for advanced prostate cancer but tumor regression is u...
<p>(<b>A</b>) Senescence associated beta-galactosidase (SA-beta-gal) staining under indicated condit...
<p>(A) LNCaP 104-R1 cells, PC-3 cells with control plasmid LNCX-2 (PC-3<sup>LNCX-2</sup>), PC-3 cell...
<p>AS LNCaP C-33 cells were seeded at a density of 2×10<sup>4</sup> cells/cm<sup>2</sup> in regular ...
<p>LNCaP cells were transduced with the indicated shRNA constructs and kept continuously in 2 µg/ml ...
<div><p>Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (...
markdownabstract__Abstract_ The LNCaP-FGC (fast growing colony) cell line, a subline derived from...
<p>(A) Immunofluorescent stainings of LNCaP cells after 7 h treatment with R1881 show co-localizatio...
textabstractSeveral effects of androgens on LNCaP-FGC prostate tumor cells showed a biphasic pattern...
<p>LNCaP cells were grown with 0.1-androgen under study. The effects were significant (P<0.01) for a...
<p>(<b>A</b>) Western blot of survival markers in LNCaP cells growing in FBS and CSS day 5, 10 and 1...
<p>L-428 cells were sorted by (A) cell size (small, middle, big) or (B) CD15/CD30 expression (SP, DP...
<p>(A) LNCaP cells were cultivated in media with charcoal-stripped FCS (CS-FCS) or control FCS for 1...
Effect of incubation with SAMe on the premature-aging phenotype of HGPS cell lines. MTT-based prolif...
Abstract Background Human induced pluripotent stem (iPS) cells have revolutionised research and spar...
Androgen-deprivation is a mainstay of therapy for advanced prostate cancer but tumor regression is u...